WallStSmart

Medline Inc. Class A Common Stock (MDLN)vsTrip.com Group Ltd ADR (TCOM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Trip.com Group Ltd ADR generates 120% more annual revenue ($62.41B vs $28.43B). TCOM leads profitability with a 53.3% profit margin vs 4.1%. TCOM trades at a lower P/E of 7.4x. TCOM earns a higher WallStSmart Score of 81/100 (A-).

MDLN

Buy

52

out of 100

Grade: C-

Growth: 6.0Profit: 5.0Value: 8.3Quality: 7.8
Piotroski: 4/9

TCOM

Exceptional Buy

81

out of 100

Grade: A-

Growth: 9.3Profit: 8.0Value: 10.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDLNUndervalued (+32.7%)

Margin of Safety

+32.7%

Fair Value

$66.92

Current Price

$42.67

$24.25 discount

UndervaluedFair: $66.92Overvalued
TCOMUndervalued (+82.1%)

Margin of Safety

+82.1%

Fair Value

$323.86

Current Price

$51.34

$272.52 discount

UndervaluedFair: $323.86Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDLN0 strengths · Avg: 0/10

No standout strengths identified

TCOM6 strengths · Avg: 9.7/10
P/E RatioValuation
7.4x10/10

Attractively priced relative to earnings

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Profit MarginProfitability
53.3%10/10

Keeps 53 of every $100 in revenue as profit

EPS GrowthGrowth
97.8%10/10

Earnings expanding 97.8% YoY

Return on EquityProfitability
21.1%9/10

Every $100 of equity generates 21 in profit

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Areas to Watch

MDLN4 concerns · Avg: 3.0/10
P/E RatioValuation
29.9x4/10

Moderate valuation

Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

Free Cash FlowQuality
$-113.00M2/10

Negative free cash flow — burning cash

TCOM2 concerns · Avg: 4.0/10
PEG RatioValuation
1.914/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : MDLN

Revenue growth of 14.8% demonstrates continued momentum.

Bull Case : TCOM

The strongest argument for TCOM centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 53.3% and operating margin at 16.5%. Revenue growth of 20.8% demonstrates continued momentum.

Bear Case : MDLN

The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.

Bear Case : TCOM

The primary concerns for TCOM are PEG Ratio, Altman Z-Score.

Key Dynamics to Monitor

MDLN profiles as a value stock while TCOM is a growth play — different risk/reward profiles.

TCOM is growing revenue faster at 20.8% — sustainability is the question.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TCOM scores higher overall (81/100 vs 52/100), backed by strong 53.3% margins and 20.8% revenue growth. MDLN offers better value entry with a 32.7% margin of safety. Both earn "Exceptional Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medline Inc. Class A Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Visit Website →

Trip.com Group Ltd ADR

CONSUMER CYCLICAL · TRAVEL SERVICES · China

Trip.com Group Limited is a travel service provider for accommodation booking, transportation ticketing, destination and package tours, corporate travel management and other travel-related services in China and internationally. The company is headquartered in Shanghai, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?